You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 216932


✉ Email this page to a colleague

« Back to Dashboard


NDA 216932 describes ALYQ, which is a drug marketed by Teva Pharms Inc and Teva Pharms Usa and is included in two NDAs. It is available from three suppliers. Additional details are available on the ALYQ profile page.

The generic ingredient in ALYQ is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 216932
Tradename:ALYQ
Applicant:Teva Pharms Inc
Ingredient:tadalafil
Patents:0
Pharmacology for NDA: 216932
Mechanism of ActionPhosphodiesterase 5 Inhibitors
Medical Subject Heading (MeSH) Categories for 216932
Suppliers and Packaging for NDA: 216932
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALYQ tadalafil TABLET;ORAL 216932 ANDA Teva Pharmaceuticals, Inc. 0480-9277 0480-9277-06 60 TABLET, FILM COATED in 1 BOTTLE (0480-9277-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Oct 12, 2022TE:AB2RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.